retatrutide glp 3 Subcutaneous Fat Loss Results: What Clinical Trials Reveal About Effectiveness and Safety NEW GPL 3 | WE

Women of childbearing potential should discuss contraception and pregnancy planning with their clinician before starting treatment

Whether youre managing diabetes, trying to lose weight, or both, its important we approach this as a teamwith trust, effort, and empathy

Please also recommend this newsletter to friends and colleagues - its free

Clinical trials show approximately 25 to 39% of weight lost on semaglutide comes from lean body mass, but much of that is liver volume reduction and body water, not skeletal muscle

Clinical evidence: Any lab results, such as A1C levels, blood pressure readings, or BMI measurements, that support the necessity of the medication

Whilst this data is promising in terms of efficacy for weight reduction and glycaemic control, the full safety and tolerability profile, including long-term GI effects, has not yet been established